Eyelash length in children and adolescents with allergic diseases

Pediatric Dermatology

Volumn 21, Issue 5, 2004, Pages 534-537

  Levy, Y ^a   Segal, N ^a   Ben Amitai, D ^a   Danon, Y L ^a  

^a S Children's Med Ctr Israel   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; EYELASH; EYELASH LENGTH; FEMALE; HUMAN; LONG EYELASH; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EYELASHES; FEMALE; HUMANS; MALE; PHENOTYPE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 5444243254     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0736-8046.2004.21501.x     Document Type: Article

References (39)

1. Harrison DA, Mallaney PB. Familial trichomegaly. Arch Ophthalmol 1997;115:1602-1603.
2. Levin AV, Seidman DJ, Nelson LB, Jackson LG. Ophthalmologic findings in the Cornelia de Lange syndrome. J Pediatr Ophthalmol Strabismus 1990;27:94-102.
3. Jackson L, Kline AD, Barr MA, Koch S. de Lange syndrome: a clinical review of 310 individuals. Am J Med Genet 1993;47:940-946.
4. Haritoglou C, Rudolph G, Kalpadakis P, Boergen KP. Congenital trichomegaly (Oliver-McFarlane syndrome): a case report with 9 years' follow-up. Br J Ophthalmol 2003;87:119-120.
5. Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPSI gene. Arch Dermatol 1999;135:774-780.
6. Hernandez-Nunez A, Fernandez-Herrera J, Buceta LR, Garcia-Diez A. Trichomegaly following treatment with interferon alpha-2b. Lancet 2002;359:1107.
7. Dikici B, Bosnak M, Dagli A, Haspolat K. Interferon alpha and hypertrichosis of eyelashes. Pediatr Infect Dis J 2002;21:448-449.
8. Ozdogan M, Gur G, Kadayifcilar S, Boyacioglu S, Ozgur O, Teletar H. An unusual adverse effect of interferon: hypertrichosis of the eyelashes. J Interferon Cytokine Res 2000;20:633-634.
9. Jayamanne DG, Dayan MR, Porter R. Cyclosporine-induced trichomegaly of accessory lashes as a cause of ocular irritation. Nephrol Dial Transplant 1996;11:1159-1161.
10. Weaver DT, Bartley GB. Cyclosporine-induced trichomegaly. Am J Ophthalmol 1990;109:239.
11. Woo TL, Francis IC. Intermittent blurred vision and trichomegaly due to latanoprost. Clin Exp Ophthalmol 2001;29:272-273.
12. Stecchi G, Saccucci S, Molinari S, De Gregorio F. Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study. Acta Ophthalmol Scand Suppl 2002;236:56-57.
13. O'Toole L, Cahill M, O'Brien C. Eyelid hypertrichosis associated with latanoprost is reversible. Eur J Ophthalmol 2001;11:377-379.
14. Strober BE, Potash S, Grossman ME. Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis 2001;67:109-110.
15. Mansberger SL, Cioffi GA. Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol 2000;118:718-719.
16. Eisenberg DL, Camras CB. A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension. Drug Saf 1999;20:505-514.
17. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthamol 1997;124:544-547.
18. Sugimoto M, Sugimoto M, Uji Y. Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Can J Ophthalmol 2002;37:342-345.
19. Santiago M, Travassos AC, Rocha MC, Souza S. Hypertrichosis in systemic lupus erythematosus (SLE). Clin Rheumatol 2000;19:245-246.
20. Sharma RC, Mahajan VK, Sharma NL, Sharma A. Trichomegaly of the eyelashes in dermatomyositis. Dermatology 2002;205:305.
21. Patrizi A, Neri I, Trestini D, Landi C, Ricci G, Masi M. Acquired trichomegaly of the eyelashes in a child with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998;11:89-91.
22. Graham DA, Sires BS. Acquired trichomegaly associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1997;115:557-558.
23. Kaplan MH, Sadick NS, Talmor M. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome. J Am Acad Dermatol 1991;25:801-804.
24. Baccard M, Morel P. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome. Cutis 1994;53:83-84.
25. Nelson HS. Advances in upper airway diseases and allergen irnrnunotherapy. J Allergy Clin Immunol 2003;111:S793-S798.
26. Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma - United States 1980-1999. MMWR CDC Surveill Summ 2002;51(5501):1-13.
27. Liu AH, Szefler SJ. Advances in childhood asthma. Hygiene hypothesis, natural history and management. J Allergy Clin Immunol 2003;111:S785-S792.
28. Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin N Am 2002;22:1-24.
29. Tinkelman D. Evaluation of the patient with chronic respiratory syndromes. In: Bierman CW, Perelman DS, Shapiro GG, Buss WW, eds. Allergy and immunology from infancy to adulthood. Philadelphia: WB Saunders, 1996.
30. Marks MB. Recognizing the allergic person. Am Fam Physician 1977;16:72-79.
31. Tosi A, Misciali C, Piraccini BM, et al. Drug-induced hair loss and hair growth: management and guidance. Drug Saf 1994;10:310-317.
32. Paus R, Costarelis G. The biology of hair follicles. N Engl J Med 1999;341:491-497.
33. Olsen EA. Hypertrichosis. In: Olsen EA, ed. Disorders of hair growth. Diagnosis and treatment. New York: McGraw-Hill, 1994:315-336.
34. Church MK, McGill JI. Human ocular mast cells. Curr Opin Allergy Clin Immunol 2002;2:419-422.
35. Paus R, van der Veen C, Eichmuller S, et al. Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol 1998;111:7-18.
36. Paus R, Maurer M, Slominski A, Czarnetzki BM. Mast cell involvement in murine hair growth. Dev Biol 1994;163:230-240.
37. Maurer M, Paus R, Czarnetzki BM. Mast cells as modulators of hair follicle cycling. Exp Dermatol 1995;4:266-271.
38. Maurer M, Fischer E, Handjiski B, et al. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 1997;77:319-332.
39. Arck PC, Handjiski B, Peters EM, et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003;162:803-814.